Bryce Johnson

Bryce Johnson is an accomplished researcher with extensive experience in molecular biology and pharmacology. As a Research Scientist I at the University of Washington, Bryce developed proficiency in molecular biology techniques while completing independent projects and supporting collaborative research. At Biogen, Bryce served as an Associate Scientist III, focusing on engineering critical mouse strains to model fibrosing human diseases using Crispr/Cas9 technology. In a Principal Scientist role at Pfizer, Bryce led discovery biology efforts in epithelial biology and mucosal immunology, while also establishing gene editing platforms in primary human cell cultures. Bryce holds a Doctor of Philosophy and a Master of Science in Pharmacology from Northeastern University, as well as dual bachelor's degrees in Biochemistry and Spanish from the University of Washington.